Bioengineered skin constructs and their use in wound healing

Plastic and Reconstructive Surgery

Volumn 127, Issue SUPPL. 1 S, 2011, Pages

  Lazic, Tamara ^a   Falanga, Vincent ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; ARTIFICIAL SKIN; BIOENGINEERING; HUMAN; INJURY; PATHOPHYSIOLOGY; PHYSIOLOGY; TISSUE ENGINEERING; WOUND HEALING;

BIOENGINEERING; HUMANS; SKIN, ARTIFICIAL; TISSUE ENGINEERING; WOUND HEALING; WOUNDS AND INJURIES;

EID: 78651340683     PISSN: 00321052     EISSN: None     Source Type: Journal    
DOI: 10.1097/PRS.0b013e3182009d9f     Document Type: Article

References (60)

1. Rheinwald JG, Green H. Serial cultivation of strains of human epidermal keratinocytes: The formation of keratinizing colonies from single cells. Cell 1975;6:331-343
2. Gallico GG III, O'Connor NE, Compton CC, Kehinde O, Green H. Permanent coverage of large burn wounds with autologous cultured human epithelium. N Engl J Med. 1984; 311:448-451
3. Compton CC, Hickerson W, Nadire K, Press W. Acceleration of skin regeneration from cultured epithelial autografts by transplantation to homograft dermis. J Burn Care Rehabil. 1993;14:653-662
4. Compton CC, Gill JM, Bradford DA, Regauer S, Gallico GG, O'Connor NE. Skin regenerated from cultured epithelial autografts on full-thickness burn wounds from 6 days to 5 years after grafting: A light, electron microscopic and immunohistochemical study. Lab Invest. 1989;60:600-612
5. Odessey R. Addendum: Multicenter experience with cultured epidermal autograft for treatment of burns. J Burn Care Rehabil. 1992;13:174-180
6. Langdon RC, Cuono CB, Birchall N, et al. Reconstitution of structure and cell function in human skin grafts derived from cryopreserved allogeneic dermis and autologous cultured keratinocytes. J Invest Dermatol. 1988;91:478-485
7. Cuono C, Langdon R, McGuire J. Use of cultured epidermal autografts and dermal allografts as skin replacement after burn injury. Lancet 1986;1:1123-1124
8. Sheridan RL, Tompkins RG. Cultured autologous epithelium in patients with burns of ninety percent or more of the body surface. J Trauma 1995;38:48-50
9. Cuono CB, Langdon R, Birchall N, Barttelbort S, McGuire J. Composite autologous-allogeneic skin replacement: Development and clinical application. Plast Reconstr Surg. 1987; 80:626-637
10. Phillips TJ, Bhawan J, Leigh IM, Baum HJ, Gilchrest BA. Cultured epidermal autografts and allografts: A study of differentiation and allograft survival. J Am Acad Dermatol. 1990; 23:189-198
11. Lattari V, Jones LM, Varcelotti JR, Latenser BA, Sherman HF, Barrette RR. The use of a permanent dermal allograft in full-thickness burns of the hand and foot: A report of three cases. J Burn Care Rehabil. 1997;18:147-155
12. Yannas IV, Burke JF, Orgill DP, Skrabut EM. Wound tissue can utilize a polymeric template to synthesize a functional extension of skin. Science 1982;215:174-176
13. Heimbach D, Luterman A, Burke J, et al. Artificial dermis for major burns: A multi-center randomized clinical trial. Ann Surg. 1988;208:313-320
14. Burke JF, Yannas IV, Quinby WC Jr, Bondoc CC, Jung WK. Successful use of a physiologically acceptable artificial skin in the treatment of extensive burn injury. Ann Surg. 1981;194: 413-428
15. Lorenz C, Petracic A, Hohl HP, Wessel L, Waag KL. Early wound closure and early reconstruction: Experience with a dermal substitute in a child with 60 per cent surface area burn. Burns 1997;23:505-508
16. Hansbrough JF, Doré C, Hansbrough WB. Clinical trials of a living dermal tissue replacement placed beneath meshed, split-thickness skin grafts on excised burn wounds. J Burn Care Rehabil. 1992;13:519-529
17. Hansbrough J. Dermagraft-TC for partial-thickness burns: A clinical evaluation. J Burn Care Rehabil. 1997;18:S25-S28
18. Boyce ST, Hansbrough JF. Biologic attachment, growth, and differentiation of cultured human epidermal keratinocytes on a graftable collagen and chondroitin-6-sulfate substrate. Surgery 1988;103:421-431
19. Hansbrough JF, Boyce ST, Cooper ML, Foreman TJ. Burn wound closure with cultured autologous keratinocytes and fibroblasts attached to a collagen-glycosaminoglycan substrate. JAMA. 1989;262:2125-2130
20. Orgill DP, Butler C, Regan JF, Barlow MS, Yannas IV, Compton CC. Vascularized collagen-glycosaminoglycan matrix provides a dermal substrate and improves take of cultured epithelial autografts. Plast Reconstr Surg. 1998;102:423-429
21. Compton CC, Butler CE, Yannas IV, Warland G, Orgill DP. Organized skin structure is regenerated in vivo from collagen- GAG matrices seeded with autologous keratinocytes. J Invest Dermatol. 1998;110:908-916
22. Werner S, Krieg T, Smola H. Keratinocyte-fibroblast interactions in wound healing. J Invest Dermatol. 2007;127:998-1008
23. Marinkovich MP. The molecular genetics of basement membrane diseases. Arch Dermatol. 1993;129:1557-1565
24. Nelson CM, Bissell MJ. Of extracellular matrix, scaffolds, and signaling: Tissue architecture regulates development, homeostasis, and cancer. Annu Rev Cell Dev Biol. 2006;22:287-309
25. Atiyeh BS, Gunn SW, Hayek SN. State of the art in burn treatment. World J Surg. 2005;29:131-148
26. Horch RE, Kopp J, Kneser U, Beier J, Bach AD. Tissue engineering of cultured skin substitutes. J Cell Mol Med. 2005; 9:592-608
27. Atiyeh BS, Costagliola M. Cultured epithelial autograft (CEA) in burn treatment: Three decades later. Burns 2007; 33:405-413
28. Schultz GS, Sibbald RG, Falanga V, et al. Wound bed preparation: A systematic approach to wound management. Wound Repair Regen. 2003;11(Suppl 1):S1-S28
29. Falanga V, Faria K. Bioengineered skin constructs. In: Lanza R, Langer R, Vacanti J, eds. Principles of Tissue Engineering. 3rd ed. Amsterdam: Elsevier Academic Press; 2007:1167
30. Steed DL. Clinical evaluation of recombinant human platelet- derived growth factor for the treatment of lower extremity ulcers. Plast Reconstr Surg. 2006;117:143S-149S; discussion 150S-151S
31. Veves A, Falanga V, Armstrong DG, Sabolinski ML; Apligraf Diabetic Foot Ulcer Study. Graftskin, a human skin equivalent, is effective in the management of noninfected neuropathic diabetic foot ulcers: A prospective randomized multicenter clinical trial. Diabetes Care 2001;24:290-295
32. Falanga V, Margolis D, Alvarez O, et al. Rapid healing of venous ulcers and lack of clinical rejection with an allogeneic cultured human skin equivalent: Human Skin Equivalent Investigators Group. Arch Dermatol. 1998;134:293-300
33. Falanga V, Sabolinski M. A bilayered living skin construct (APLIGRAF) accelerates complete closure of hard-to-heal venous ulcers. Wound Repair Regen. 1999;7:201-207
34. Marston WA, Hanft J, Norwood P, Pollak R. The efficacy and safety of Dermagraft in improving the healing of chronic diabetic foot ulcers: Results of a prospective randomized trial. Diabetes Care 2003;26:1701-1705
35. Mostow EN, Haraway GD, Dalsing M, Hodde JP, King D. Effectiveness of an extracellular matrix graft (OASIS wound matrix) in the treatment of chronic leg ulcers: A randomized clinical trial. J Vasc Surg. 2005;41:837-843
36. Benson A, Dickson WA, Boyce DE. Burns. BMJ. 2006;332: 649-652
37. Nguyen DQ, Potokar TS, Price P. An objective long-term evaluation of Integra (a dermal skin substitute) and split thickness skin grafts, in acute burns and reconstructive surgery. Burns 2010;36:23-28
38. Waymack P, Duff RG, Sabolinski M. The effect of a tissue engineered bilayered living skin analog, over meshed splitthickness autografts on the healing of excised burn wounds. The Apligraf Burn Study Group. Burns 2000;26:609-619
39. Kalyanaraman B, Boyce S. Assessment of an automated bioreactor to propagate and harvest keratinocytes for fabrication of engineered skin substitutes. Tissue Eng. 2007;13:983-993
40. Powell HM, Supp DM, Boyce ST. Influence of electrospun collagen on wound contraction of engineered skin substitutes. Biomaterials 2008;29:834-843
41. Donohue KG, Carson P, Iriondo M, et al. Safety and efficacy of a bilayered skin construct in full-thickness surgical wounds. J Dermatol. 2005;32:626-631
42. Shen JT, Falanga V. Treatment of venous ulcers using a bilayered living skin construct. Surg Technol Int. 2000;IX: 77-80
43. de Imus G, Golomb C, Wilkel C, Tsoukas M, Nowak M, Falanga V. Accelerated healing of pyoderma gangrenosum treated with bioengineered skin and concomitant immunosuppression. J Am Acad Dermatol. 2001;44:61-66
44. Falabella AF, Valencia IC, Eaglstein WH, Schachner LA. Tissue- engineered skin (Apligraf) in the healing of patients with epidermolysis bullosa wounds. Arch Dermatol. 2000;136:1225-1230
45. Falanga V. Classifications for wound bed preparation and stimulation of chronic wounds. Wound Repair Regen. 2000;8: 347-352
46. Panuncialman J, Falanga V. The science of wound bed preparation. Surg Clin North Am. 2009;89:611-626
47. Brem H, Balledux J, Sukkarieh T, et al. Healing of venous ulcers of long duration with a bilayered living skin substitute: Results from a general surgery and dermatology department. Dermatol Surg. 2001;27:915-919
48. Kim BC, Kim HT, Park SH, et al. Fibroblasts from chronic wounds show altered TGF-beta-signaling and decreased TGFbeta type II receptor expression. J Cell Physiol. 2003;195:331-336
49. Loots MA, Lamme EN, Mekkes JR, Bos JD, Middelkoop E. Cultured fibroblasts from chronic diabetic wounds on the lower extremity (non-insulin-dependent diabetes mellitus) show disturbed proliferation. Arch Dermatol Res. 1999;291: 93-99
50. Brem H, Tomic-Canic M. Cellular and molecular basis of wound healing in diabetes. J Clin Invest. 2007;117:1219-1222
51. Stojadinovic O, Brem H, Vouthounis C, et al. Molecular pathogenesis of chronic wounds: The role of beta-catenin and c-myc in the inhibition of epithelialization and wound healing. Am J Pathol. 2005;167:59-69
52. Mansbridge J, Liu K, Patch R, Symons K, Pinney E. Threedimensional fibroblast culture implant for the treatment of diabetic foot ulcers: Metabolic activity and therapeutic range. Tissue Eng. 1998;4:403-414
53. Badiavas EV, Paquette D, Carson P, Falanga V. Human chronic wounds treated with bioengineered skin: Histologic evidence of host-graft interactions. J Am Acad Dermatol. 2002; 46:524-530
54. Nahm WK, Philpot BD, Adams MM, et al. Significance of N-methyl-D-aspartate (NMDA) receptor-mediated signaling in human keratinocytes. J Cell Physiol. 2004;200:309-317
55. Falanga V, Butmarc J, Cha J, Yufit T, Carson P. Migration of the epidermal over the dermal component (epiboly) in a bilayered bioengineered skin construct. Tissue Eng. 2007;13: 21-28
56. Griffiths M, Ojeh N, Livingstone R, Price R, Navsaria H. Survival of Apligraf in acute human wounds. Tissue Eng. 2004;10:1180-1195
57. Phillips TJ, Manzoor J, Rojas A, et al. The longevity of a bilayered skin substitute after application to venous ulcers. Arch Dermatol. 2002;138:1079-1081
58. Fivenson DP, Scherschun L, Cohen LV. Apligraf in the treatment of severe mitten deformity associated with recessive dystrophic epidermolysis bullosa. Plast Reconstr Surg. 2003; 112:584-588
59. Tremblay PL, Hudon V, Berthod F, Germain L, Auger FA. Inosculation of tissue-engineered capillaries with the host's vasculature in a reconstructed skin transplanted on mice. Am J Transplant. 2005;5:1002-1010
60. Falanga V. Bone marrow cells can manipulate healing. Blood 2009;113:982-983